Press Release: Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026

Dow Jones
08/12
NEW PRAGUE, Minn.--(BUSINESS WIRE)--August 11, 2026-- 

Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 fourth quarter ended June 30, 2026, on Tuesday, August 25th, 2026, after the close of the stock market. Company management will host a conference call on the same day at 5:00 p.m. Eastern Time to discuss the results.

Interested parties may participate in the call by dialing (877) 407-3982 (Toll Free) or (201) 493-6780.

The live webcast of the call will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electromed Fiscal Q4 2026 Earnings Call

For those who cannot listen to the live broadcast, a replay will be available by dialing (844) 512-2921 (Toll Free) or (412) 317-6671 and referencing Access ID 13761827. Additionally, a replay of the webcast will be available in the Investor Relations section of Electromed's web site at: Events & Presentations

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest$(R)$ Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260811725802/en/

 
    CONTACT:    Brad Nagel, Chief Financial Officer 

(952) 758-9299

investorrelations@electromed.com

Mike Cavanaugh, Investor Relations

ICR Healthcare

(617) 877-9641

mike.cavanaugh@icrhealthcare.com

 
 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10